Drug recall · February 15, 2023
Atropine Sulfate Ophthalmic Solution recall
Why: Failed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Atropine Sulfate Ophthalmic Solution, USP 1%, For Topical Application To The Eye, 2 mL bottle, Sterile, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. NDC: 17478-215-02
- Lots / codes
Lot: 081031A, Exp 2/28/2023
- Quantity
- 45,117 Bottles
- Company
- Akorn, Inc., Gurnee, IL
- Distribution
- Nationwide in the USA and Puerto Rico
- Initiated
- January 30, 2023 · Voluntary: Firm initiated
- Classified
- February 8, 2023
- Reported
- February 15, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Atropine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.